113 related articles for article (PubMed ID: 21590869)
1. Efficient Liposomal Nanocarrier-mediated Oligodeoxynucleotide Delivery Involving Dual Use of a Cell-Penetrating Peptide as a Packaging and Intracellular Delivery Agent.
Saw PE; Ko YT; Jon S
Macromol Rapid Commun; 2010 Jul; 31(13):1155-62. PubMed ID: 21590869
[TBL] [Abstract][Full Text] [Related]
2. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
[TBL] [Abstract][Full Text] [Related]
3. A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system.
Zhang Q; Tang J; Fu L; Ran R; Liu Y; Yuan M; He Q
Biomaterials; 2013 Oct; 34(32):7980-93. PubMed ID: 23891517
[TBL] [Abstract][Full Text] [Related]
4. Intracellular delivery of oligonucleotide conjugates and dendrimer complexes.
Juliano RL
Ann N Y Acad Sci; 2006 Oct; 1082():18-26. PubMed ID: 17145920
[TBL] [Abstract][Full Text] [Related]
5. Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules.
Farkhani SM; Valizadeh A; Karami H; Mohammadi S; Sohrabi N; Badrzadeh F
Peptides; 2014 Jul; 57():78-94. PubMed ID: 24795041
[TBL] [Abstract][Full Text] [Related]
6. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
Li SD; Huang L
Mol Pharm; 2006; 3(5):579-88. PubMed ID: 17009857
[TBL] [Abstract][Full Text] [Related]
7. Cell-penetrating peptide-based systems for nucleic acid delivery: a biological and biophysical approach.
Trabulo S; Cardoso AL; Cardoso AM; Düzgüneş N; Jurado AS; de Lima MC
Methods Enzymol; 2012; 509():277-300. PubMed ID: 22568911
[TBL] [Abstract][Full Text] [Related]
8. Oxidized ultrashort nanotubes as carbon scaffolds for the construction of cell-penetrating NF-kappaB decoy molecules.
Crinelli R; Carloni E; Menotta M; Giacomini E; Bianchi M; Ambrosi G; Giorgi L; Magnani M
ACS Nano; 2010 May; 4(5):2791-803. PubMed ID: 20411956
[TBL] [Abstract][Full Text] [Related]
9. Cell-penetrating peptides (CPPs) as a vector for the delivery of siRNAs into cells.
Nakase I; Tanaka G; Futaki S
Mol Biosyst; 2013 May; 9(5):855-61. PubMed ID: 23306408
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the use of cell-penetrating peptides for medical and biological applications.
Fonseca SB; Pereira MP; Kelley SO
Adv Drug Deliv Rev; 2009 Sep; 61(11):953-64. PubMed ID: 19538995
[TBL] [Abstract][Full Text] [Related]
11. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
[TBL] [Abstract][Full Text] [Related]
12. Distinct transduction modes of arginine-rich cell-penetrating peptides for cargo delivery into tumor cells.
Ma DX; Shi NQ; Qi XR
Int J Pharm; 2011 Oct; 419(1-2):200-8. PubMed ID: 21843610
[TBL] [Abstract][Full Text] [Related]
13. Enhanced intracellular delivery using arginine-rich peptides by the addition of penetration accelerating sequences (Pas).
Takayama K; Nakase I; Michiue H; Takeuchi T; Tomizawa K; Matsui H; Futaki S
J Control Release; 2009 Sep; 138(2):128-33. PubMed ID: 19465072
[TBL] [Abstract][Full Text] [Related]
14. An antisense oligonucleotide carrier based on amino silica nanoparticles for antisense inhibition of cancer cells.
Peng J; He X; Wang K; Tan W; Li H; Xing X; Wang Y
Nanomedicine; 2006 Jun; 2(2):113-20. PubMed ID: 17292123
[TBL] [Abstract][Full Text] [Related]
15. TP10, a delivery vector for decoy oligonucleotides targeting the Myc protein.
El-Andaloussi S; Johansson H; Magnusdottir A; Järver P; Lundberg P; Langel U
J Control Release; 2005 Dec; 110(1):189-201. PubMed ID: 16253378
[TBL] [Abstract][Full Text] [Related]
16. Enhanced delivery of cell-penetrating peptide-peptide nucleic acid conjugates by endosomal disruption.
Shiraishi T; Nielsen PE
Nat Protoc; 2006; 1(2):633-6. PubMed ID: 17406290
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of cell-penetrating peptides.
Sarko D; Beijer B; Garcia Boy R; Nothelfer EM; Leotta K; Eisenhut M; Altmann A; Haberkorn U; Mier W
Mol Pharm; 2010 Dec; 7(6):2224-31. PubMed ID: 20845937
[TBL] [Abstract][Full Text] [Related]
18. Chemically modified cell-penetrating peptides for the delivery of nucleic acids.
Mäe M; Andaloussi SE; Lehto T; Langel U
Expert Opin Drug Deliv; 2009 Nov; 6(11):1195-205. PubMed ID: 19831582
[TBL] [Abstract][Full Text] [Related]
19. Insights into the cellular trafficking of splice redirecting oligonucleotides complexed with chemically modified cell-penetrating peptides.
Hassane FS; Abes R; El Andaloussi S; Lehto T; Sillard R; Langel U; Lebleu B
J Control Release; 2011 Jul; 153(2):163-72. PubMed ID: 21536086
[TBL] [Abstract][Full Text] [Related]
20. S4(13)-PV cell penetrating peptide and cationic liposomes act synergistically to mediate intracellular delivery of plasmid DNA.
Trabulo S; Mano M; Faneca H; Cardoso AL; Duarte S; Henriques A; Paiva A; Gomes P; Simões S; de Lima MC
J Gene Med; 2008 Nov; 10(11):1210-22. PubMed ID: 18729238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
